"Ιδρύθηκε το 1984 στο Μαρούσι, με στόχο την παροχή ποιοτικών υπηρεσιών υγείας στην Ελλάδα. Παρουσίασε υψηλούς ρυθμούς ανάπτυξης, δημιούργησε νέα δεδομένα στον χώρο της υγείας και προσέφερε υψηλής ποιότητας υπηρεσίες, εφάμιλλες με αυτές των πλέον σύγχρονων νοσηλευτικών ιδρυμάτων της Δυτικής Ευρώπης και των Η.Π.Α. Το Ιατρικό Κέντρο Αθηνών αποτελείται από τη Γενική Κλινική, το Παιδιατρικό Κέντρο Αθηνών και τη ΓΑΙΑ Μαιευτική – Γυναικολογική. Διαθέτει 319 κλίνες (περιλαμβανομένων αυτών του Παιδιατρικού Κέντρου και της ΓΑΙΑ Μαιευτικής - Γυναικολογικής), οι οποίες υποστηρίζονται από 19 Χειρουργικές Αίθουσες και Μονάδα Εντατικής Θεραπείας 24 κλινών."

During the past decade, Athens Medical Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Athens Medical Center" #1 sponsor was "Celgene" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Actelion" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Athens Medical Center" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Athens Medical Center" are "Crohn Disease" (2 trials), "Alzheimer Disease" (1 trials), "Breast Cancer" (1 trials), "Crohn's Disease" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Athens Medical Center" in a lesser frequency.

Most popular intervention types in "Athens Medical Center" are "Drug" (11 trials), "Device" (3 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "GED-0301" (3 trials), "Nivolumab" (2 trials), "BI 1015550" (1 trials) and "BI 425809 dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Athens Medical Center" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Athens Medical Center". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Athens Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Athens Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".